Resolute Advisors LLC Amgen Inc Transaction History

Resolute Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $23,467 - $26,856	-118 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $2,547 - $2,984	-12 Reduced 9.23%	118 $25,000
Q2 2021 Dec 27, 2021	BUY	$233.58 - $259.14 $30,365 - $33,688	130 New	130 $32,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $30,365 - $33,688	-130 Closed	0 $0
Q1 2021 Dec 27, 2021	BUY	$221.91 - $258.6 $28,848 - $33,618	130 New	130 $29,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $3,328 - $3,879	-15 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $3,245 - $3,865	15 New	15 $3,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.